Current status of granulocyte transfusion therapy.
D000380:Agranulocytosis / Q000628:therapy*; D000818:Animals; D001424:Bacterial Infections / Q000150:complications / Q000209:etiology / Q000517:prevention & control / Q000628:therapy*; D001782:Blood Donors; D001793:Blood Preservation; D001803:Blood Transfusion; D002177:Candidiasis / Q000150:complications / Q000628:therapy; D002469:Cell Separation / Q000379:methods; D004195:Disease Models, Animal; D005069:Evaluation Studies as Topic; D005374:Filtration; D006098:Granulocytes / Q000502:physiology / Q000637:transplantation*; D006650:Histocompatibility Testing; D006801:Humans; D007937:Leukapheresis; D007938:Leukemia / Q000150:complications; D017708:Leukocyte Transfusion; D009181:Mycoses / Q000628:therapy*; D009503:Neutropenia / Q000150:complications / Q000628:therapy*; D018805:Sepsis / Q000628:therapy